Tissue-specific transcription factors play an essential role in establishing cell identity during development. We review our knowledge of the molecular events involved in the activation of the gene encoding the tissue-specific transcription factor HNFla (LFB1). The available data suggest that the maternal factors OZ-1, HNF4c~ and HNF4/3 act as initial activators of the HNFlc~ promoter. We present evidence suggesting that the mesoderm-inducing factor activin A plays a critical role by acting through the HNF4 binding site of the HNFla promoter. The activity of this embryonic morphogen seems to form a gradient opposing the distribution of the maternal HNF4 proteins that are concentrated at the animal pole of the egg. After zygotic gene transcription the HNFlc~-related transcription factor HNF1/3 accumulates faster than HNFlc~ itself and thus is likely to contribute to the activation of the HNFla transcription via the HNF1 binding site. The cofactor of the HNF1 proteins (DCoH) is present throughout development and thus cannot limit the activation potential of HNFlc~ in early development. Our results provide a detailed description of setting up the expression pattern of a tissue-specific transcription factor during embryogenesis. © 1997 Elsevier Science Ireland Ltd.
An evolutionarily conserved regulatory system
Tissue-specific transcription factors play a crucial role in selective gene expression in eukaryotes and thus determine differentiation processes to a large extent. It is generally assumed that each cell type has its unique pattern of distinct transcription factors involving probably more than 100 different species. These transcription factors recognize defined regulatory DNA elements in the promoter and enhancer sequences of the target genes. Typically, any given gene contains a series of binding sites for distinct transcription factors which mediate its activation (for examples see Tronche and Yaniv, 1992) . Thus, a complex interaction of various factors defines the activity of a single gene with some binding sites that are more important than others.
As an approach to identify gene regulatory elements playing a major role, we investigated 10 years ago the functional performance of the liver specifically active albumin promoter of the amphibian Xenopus. We assumed that crucial regulatory elements mediating hepatocyte-specific expression would have been conserved during vertebrate evolution and therefore used mammalian cell cultures. This approach seemed quite attractive as the liver in vertebrates represents an evolutionarily conserved feature. Comparing the function of the albumin promoter by transient transfection assays in cell lines of hepatic and fibroblastic origin, we succeeded in defining a regulatory element mediating hepatocyte-specific transcription (Schorpp et al., 1988; Ryffel et al., 1989) . Most notably, we detected this regulatory element exclusively, although in corresponding experiments using mammalian albumin promoters other groups have identified binding sites interacting with different transcrip-tion factors (reviewed in Tronche and Yaniv, 1992) . The existence of this conserved regulatory element between Xenopus and manunals suggests that we have detected the most important control element of the albumin promoter.
The tissue-specific transcription factor HNFI~, our key for further experimentation
Subsequently it turned out that this evolutionarily conserved regulatory element is specifically recognized by HNFlc~ and HNF1/3, two related tissue-specific transcription factors encoded by two distinct genes. These two factors were initially cloned from mammalian sources (reviewed in Cereghini, 1996) and subsequently also from Xenopus (Bartkowski et al., 1993; Demartis et al., 1994) . Later a HNF1 homologue was also described in fish (Deryckere et al., 1995) , but so far no Drosophila or any other non-vertebrate form has been reported. Based on their protein structure HNFlc¢ and /3 belong to the homeodomain proteins but their homeobox is unique: it contains 21 additional amino acids and, based on three dimensional structural analysis, this amino acid stretch loops out between the highly conserved helix II and helix III of the homeodomain (Ceska et al., 1993) . Furthermore, HNF1 proteins contain a second DNA binding domain that is related to the POU A domain, a dimerization domain at the N-terminus and a transactivation domain at the C-terminus. All these structural features are common to the ot and/3 form of HNF1 and are highly conserved between the various vertebrate species analyzed (reviewed in Cereghini, 1996) .
Using cloned cDNA probes and antibodies raised against recombinant proteins it turned out that HNFla is not restricted to hepatocytes but also present in renal tubules, the intestine, the stomach and the pancreas (Tronche and Yaniv, 1992) . As this tissue-specific expression pattern seems to be conserved between Xenopus and mammals (Weber et al., 1996a) , we assume that a specific HNFla distribution is essential for the proper activation of target genes in vertebrate tissues. Whereas in hepatocytes more than 20 potential target genes of HNFla are defined, only a few candidate genes are known in the other cell types (reviewed in Mendel and Crabtree, 1991; and e.g. Clairmont et al., 1994; Wu et al., 1994) . Since HNFla is found in nonhepatic cell types we conclude that HNFlc¢ per se is not sufficient for liver-specific gene control. Rather, we believe that HNFla is one member of a set of transcription factors involved in liver-specific gene control and that it plays an essential role in other tissues also. The non-hepatic role of HNFlc~ has been documented by the phenotype of the HNFlc~ knock-out mice: The homozygous animals suffer predominantly from a renal failure that leads to death within a few weeks after birth (Pontoglio et al., 1996) . Furthermore, it turned out recently that a specific inherited form of human diabetes (MODY3) is due to a defective HNFla gene (Yamagata et al., 1996) suggesting that HNFla plays an essential role in pancreatic insulin production.
Besides the significance of HNFle¢ in determining the expression of specific target genes we have been interested over the last years in the mechanisms responsible for tissuespecific expression of HNFlot itself. The answer to this question may be quite simple in principle, as we would assume that other well defined transcription factors control the tissue-restricted expression of HNFlu. A more fundamental problem would be to identify the events leading to tissue-specific expression of HNFla during embryonic development and this problem has interested our group very much over the past few years. Assuming that this embryonic control might be an evolutionarily conserved mechanism we decided to analyze these events in the Xenopus system, as in amphibian species the molecular events can be manipulated easily during early embryonic stages (Kay and Peng, 1991) . We anticipate that our findings will also illuminate the processes occurring in mammalian development.
The pattern of HNFI~ expression in Xenopus development
As tools to study the molecular events that define the embryonic expression pattern of HNFlc¢, we cloned the cDNA and the genomic sequences encoding HNFI~, expressed the recombinant protein, and prepared monoclonal antibodies specific for HNFlc~ (Bartkowski et al., 1993; Zapp et al., 1993a) . With the help of these probes we determined the time course of HNFla expression during early development. As summarized in Fig. 1 , HNFlc~ gene transcription starts after the blastula stage as HNFlu transcripts appear only after mid-blastula transition, the time point when zygotic gene activity occurs in Xenopus. The amount of HNFlc~ mRNA accumulates by about ten-fold in the hatched larvae and at this stage HNFI~ protein can be detected in. Western blots. The apparent delay in HNFlc~ protein accumulation compared to the corresponding mRNA may either reflect the quite insensitive protein assay or indicate some translational control. Obviously, embryonic HNFI~ gene transcription is initiated prior to organogenesis, but high levels of HNFla protein are only observed when well defined tissues have already been differentiated. At these advanced stages of development HNFlc¢ protein can be localized predominantly in the nuclei of the pronephros, but is also detectable in the nuclei of the liver and the gut (Weber et al., 1996a) . This implies that HNFlc~ acts at these larval stages in the tissues equivalent to the ones where it is expressed in the adult. As illustrated in Fig. 1 , albumin gene transcripts appear after significant levels of HNFlc~ protein have accumulated and this is consistent with our assumption that the albumin gene is dependent on HNFla activity.
To Bartkowski et al. (1993) and Weber et al. (1996a) . + refers to low amounts and + + indicates an approximately ten-fold higher amount. The stages are as defined by Nieuwkoop and Faber (1975) .
embryogenesis we also investigated the expression pattern of DCoH, a positive cofactor involved in the stimulation of HNF1 activity (reviewed in Suck and Ficner, 1996; Cronk et al., 1996) . This protein plays a bifunctional role as it is also an enzymatic factor in the cytoplasm involved in tetrahydrobiopterin regeneration. By immunohistochemistry we could show that in the Xenopus embryo DCoH colocalizes with HNFhx in the pronephric tubules, the liver and the gut. In the adult DCoH is absent in the stomach and intestine (Pogge v. Strandmann and Ryffel, 1995) which contain HNFlot (Weber et al., 1996a) . This implies that the presence of DCoH modulates the function of HNFlot in a tissuespecific way. This assumption is strongly supported by the finding that recombinant DCoH stabilizes HNF1/DNA complexes (Mendel et al., 1991; Rhee et al., 1997) and even promotes the interaction with suboptimal DNA target sequences (Rhee et al., 1997) . To our surprise we found DCoH also in the retina epithelium of the eye where no HNF1 proteins are present. As DCoH is located in the nuclei of the retina we exclude the possibility that it functions as a cytoplasmic enzyme but we speculate that it interacts with
another not yet identified transcription factor. A similar situation occurs in the egg which lacks HNF1 proteins but contains DCoH as a maternal component (see Fig. 2 ). Again we assume that maternal DCoH cooperates with as yet unidentified maternal transcription factors, as DCoH migrates into the nuclei at early blastula stages prior to the start of zygotic gene transcription (Pogge v. Strandmann and Ryffel, 1995) .
In conclusion, our descriptive analysis of HNF1 ot expression establishes that this gene is transcriptionally activated very early in embryogenesis prior to organogenesis. However, the protein accumulates quite slowly and in later stages when significant levels have accumulated it is localized in the same tissues as in the adult.
The transcription factors involved in embryonic activation of HNFI~ gene transcription
Having established that HNFlc~ transcription occurs very early in embryogenesis, we investigated the factors that might trigger these events. To approach this question we decided to analyze the HNFlot promoter as the target of embryonic gene activation. Therefore, we injected HNFlot promoter CAT reporter constructs into fertilized Xenopus eggs. This approach is technically quite easy in the amphibian system compared to the corresponding experiments in the mouse, and therefore many different constructs can be analyzed within a short period of time. However, the injected gene copies are not integrated into the Xenopus genome as they cannot be injected into the egg nucleus, and therefore persist instead as transient transgenes (Andres et al., 1984) . Nevertheless, these injection experiments allowed us to prove that a promoter construct of a few hundred nucleotides is sufficient for preferential CAT activity in the middle part of the hatched Xenopus larvae where the tissues expressing endogenous HNFla, i.e. pronephros, liver and gut, are located (Zapp et al., 1993b) . More significantly, we could also prove that a rat HNFla promoter construct is specifically activated in this HNF1 a-expressing section of the larvae as well. This documents that the essential regulatory elements of the HNFla promoter have been conserved during vertebrate evolution and that the Xenopus system may be used to analyze mammalian promoters as well. Our finding that HNFla promoter constructs are activated in a way reflecting the activity of the endogenous gene was a major breakthrough, as it allowed us to define the elements of the HNFla promoter that mediate correct embryonic expression. By deletion analysis and the introduction of defined point mutations we could identify four elements in the Xenopus promoter involved in embryonic HNFla gene activation (Zapp et al., 1993b; Holewa et al., 1996) . As shown in Fig. 3 , these elements (read 5' to 3') are the OZ element, the binding sites for HNF1 and HNF4 as well as the transcription start site. All these regulatory elements except the HNF1 binding site were also identified in the rat HNF1 a promoter documenting the evolutionary conservation ( Fig. 3) . Concerning the nature of the factor interacting with the OZ element, Krieg's group has shown that the Xenopus egg contains the maternal factor OZ-1 that specifically interacts with the OZ element (Ovsenek et al., 1992; Krieg et al., 1993) . In gel retardation assays we could show that apparently the same factor interacts with the OZ element of the HNFla promoter (Weber et al., 1996a) . As the consensus sequence of these various OZ elements contains the TCTC motif (i.e. GAGA on the opposite strand) we speculate that the factor interacting with this element is the vertebrate homologue of the Drosophila GAGA factor that is also a maternal component important in early embryogenetic events (reviewed in Granok et at., 1995). However, so far the molecular nature of the OZ binding factor OZ-1 has not been elucidated.
OZ elements were initially identified in injection experiments of Xenopus promoters of the N-CAM and GS 17 gene, both activated early in embryogenesis (Ovsenek et al., 1992) . Since these two genes show an expression pattern distinct from HNFla, we conclude that the OZ sequence is not sufficient for HNFla gene control. Indeed, by mutating the binding sites for HNF1 and HNF4 we could show that both these sites contribute to the activation of the injected HNFla promoter and that only their simultaneous absence completely abolishes embryonic activation of the transgene (Holewa et al., 1996) .
Mutational analysis of the injected HNFltx promoter construct has shown that a binding site for HNF1 contributes to the activity of the injected promoter. This might imply an autoregulatory event that functions as soon as some HNFla protein has accumulated and thus stabilizes the HNFla expression. However, this binding site might also be a target for the related transcription factor HNF1/3 that recognizes essentially the same DNA sequence (reviewed in Tronche and Yaniv, 1992; Cereghini, 1996) . To explore the possibility that HNF1/3 might contribute to the embryonic activation of the HNFla gene we determined the presence of this transcription factor during Xenopus development. Based on Western blots we observed that HNF1/3 is detectable at late gastrula (Pogge v. Strandmann et al., in preparation) and thus appears much earlier than HNFla (summarized in Fig. 2 ). These findings reflect the earlier appearance of HNFI/3 mRNA noted previously (Demartis et al., 1994) . Therefore, it seems likely that HNF1/3 acts initially through the HNF1 binding site of the HNFla promoter and we also assume that the cofactor DCoH, present as a maternal factor, cooperates in this regulatory process (Fig. 2) . In this context it is noteworthy that in mammals the appearance of HNF1/3 also precedes the accumulation of HNFla (De Simone et al., 1991; Lazarro et al., 1992) . Obviously, this differential expression pattern of the two related transcription factors has been maintained during evolution and therefore may have some fundamental function.
HNF4, known as a tissue-specific transcription factor, is a maternal component in Xenopus
To further validate the significance of the HNF4 binding site of the HNF 1 a promoter we injected a minimal promoter construct retaining the binding sites for OZ-1 and HNF4 in front of the TATA box. As shown in Fig. 4 , this promoter is preferentially activated in the middle part of the injected embryo and thus retains proper embryonic activation. If the HNF4 binding site is mutated in this construct the regulatory potential of the promoter is completely lost in injected embryos.
This experiment supports our data that the HNF4 binding site plays a major role in HNFI~ gene activation. To verify this finding by an alternative approach we injected HNF4a mRNA into fertilized eggs and analyzed the expression of the endogenous HNFla gene by Western blots. We could show that in injected embryos HNFla protein can be detected already in the neurula stage and thus is activated much earlier compared to normal embryos (Nastos et al., in preparation). Furthermore, if hatched larvae were dissected into head, middle part and tail, HNFla protein could be detected in the entire embryo and was not restricted to the middle part as found in uninjected controls (Holewa et al., 1996) . This ectopic expression of the endogenous HNFla upon artificial introduction of the transcription factor HNF4 Xenopus HNFla promoter -594
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Rat HNFla promoter -410 -282 -133 Fig. 3 . Structures of the Xenopus and rat HNFlc~ promoters mediating embryonic activation. The various elements essential for full activity are indicated. The numbers refer to the distance to the translation start. For details see Zapp et al. (1993b) and Holewa et al. (1996) .
gives further evidence that HNF4 is upstream of HNFlot in the transcriptional cascade of the embryo. Based on the apparently important role of HNF4 in the activation of HNFlot gene transcription during embryogenesis we became interested in the expression of HNF4 in Xenopus. We expected that HNF4 would be present prior to HNF1 ot and as HNF1 ot gene transcription starts soon after mid blastula transition we hoped to find a maternal HNF4 transcription factor. Until that time HNF4 was known in mammalian systems as a tissue-specific transcription factor with a tissue distribution very similar to HNFlct (reviewed in Sladek, 1994; Cereghini, 1996) . Using a rat eDNA probe for screening a Xenopus liver eDNA library we observed mtaliddle part ! relative CAT activity Fig. 4 . The HNF4 binding site plays a crucial role for embryonic activation of the HNFlc~ promoter. A promoter construct was made by deleting the 293 nucleotides between the OZ-1 element and the HNF4 binding site. This promoter CAT construct was injected into fertilized Xenopus eggs and the CAT activity determined in the dissected larvae of stage 36 (Nieuwkoop and Faber, 1975) . The CAT activity in the tail was used for standardization. For further details see Zapp et al. (1993b) and Holewa et al. (1996) .
,! is] m Ig R Fig. 5 . The zinc finger region of the HNF4 protein family. The amino acid sequence of the DNA binding region of HNF4a illustrating the binding of zinc ions (reviewed in Beato et al., 1995) . The P-box, the characteristic hallmark of the HNF4 family (Sladek, 1994) is indicated. The DNA binding region of HNF4c~ of Xenopus and mammals is identical (Holewa et al., 1996) . The amino acid changes found in the Xenopus HNF413 (Holewa et al., 1997) and human HNF47 (Drewes et al., 1996) are indicated. that HNF4 was encoded by two distinct genes (Holewa et al., 1997) . Based on the substantial sequence differences we do not believe that these genes resemble the pseudo-alleles commonly found in Xenopus due to its genome duplication during evolution. The factor most similar to the rat protein we named HNF4ot, whereas the other component was called HNF4/3. HNF4 is a member of the orphan receptors of the steroid hormone receptor superfamily and thus contains a zinc finger as DNA binding domain (Sladek, 1994) . As summarized in Fig. 5 , this region is completely conserved between Xenopus HNF4ot and the HNF4 previously found in mammals (Sladek, 1994) . In contrast, in this region there are four amino acid substitutions between the ot and/3 proteins. All these changes are outside of the highly conserved parts of the zinc finger (reviewed in Beato et al., 1995) and involve mostly conservative amino acid changes. In the search for a mammalian homologue of HNF4/3 we found, in a human kidney cDNA library, a third HNF4 variant that we refer to as HNF43, (Drewes et al., 1996) . The distinction can best be seen in the zinc finger domain of HNF4"y that differs from the ot as well as the/3 protein as shown in Fig. 5 . With antibodies specific for HNF4ot and HNF4/3 we could show that in Xenopus both these transcription factors have distinct expression profiles in the various tissues analyzed. Whereas HNF4a is expressed in liver and kidney, HNF4/3 has a broader expression profile as it is also present in stomach, intestine, lung, ovary and testis (Holewa et al., 1997) . Apparently, the a and /3 forms of the Xenopus HNF4 together have an expression pattern similar to the one reported for HNF4o~ in mammals (Duncan et al., 1994; Taraviras et al., 1994) .
Investigating the appearance of HNF4a and HNF4/3 protein during embryogenesis, we observed that both proteins are maternal components of the egg (Holewa et al., 1996; Holewa et al., 1997) . This implies that we have identified maternal transcription factors that trigger a transcriptional cascade involved in embryonic gene activation. Most significantly, in Drosophila a HNF4 homologue has been identified and at least the RNA has been found as a maternal component (Zhong et al., 1993) suggesting that HNF4 also plays a critical role in the early development of invertebrates. In mammals an early function of HNF4c~ is established as well, since HNF4a knock-out mice fail to undergo normal gastrulation . This developmental arrest seems to be due to the absence of HNF4a in the extraembryonic visceral endoderm, where it is probably needed for the expression of secreted factors essential for normal development. Consistent with this hypothesis, specific complementation of the HNF4a knock-out mice with tetraploid normal visceral endoderm rescues the early development of the embryos deficient in HNF4t~ (Duncan et al., 1997) . Clearly, these data demonstrate an early function of HNF4t~ in mammalian embryogenesis, but there are no experiments to show whether HNF4ot is also a maternal component in mammalian eggs.
Analyzing the level of HNF4 proteins throughout Xenopus development, we did not observe any major change (Holewa et al., 1996; Holewa et al., 1997) , but investigating HNF4a and/3 expression on the RNA level we found substantial changes: whereas HNF4c~ is expressed early during oogenesis and is absent in the egg, HNF4/3 is first detected in the latest stage of oogenesis and transcripts are present in the egg and early cleavage stages. Furthermore, zygotic • HNF4a transcripts appear in early gastrula and accumulate during further embryogenesis, whereas HNF4/3 mRNA transiently appears during gastrulation before it accumulates again at the tailbud stage. This distinct expression profile between these two HNF4 proteins implies that the c~ and/3 isoforms are under different regulatory control and suggests that they have distinct functions.
Opposing gradients of the HNF4 transcription factor and of the activin A morphogen may cooperate in HNFla induction
Based on the fact that HNF4 plays a major role in HNFlc~ gene activation and that HNF4c~ and/3 proteins are present as maternal components in the Xenopus eggs, it is highly likely that HNF4 is at the top of a transcriptional cascade operative in early embryogenesis. To get some more insight we investigated the spatial distribution of maternal HNF4. Most interestingly, we could show that HNF4a as well as HNF4/3 are distributed in a gradient in the egg with the highest concentration at the animal pole (Holewa et al., 1996; Holewa et al., 1997) . In the blastula stage we observed that HNF4 protein starts to enter the nucleus, implying that it has some nuclear function at mid blastula transition when zygotic transcription in the embryo starts. We assume that the uneven distribution of matemal HNF4 is a crucial characteristic that triggers a region-specific activation of HNF4 target genes such as the HNFle¢ promoter. The maternal transcription factor Xrel has also been observed to be distributed in a gradient in the early embryo and to enter the nuclei at mid blastula transition (Bearer, 1994) , but in this case the potential target genes have not yet been identified. Another nuclear translocating transcription factor in early Xenopus embryogenesis is the maternal CCAAT factor that apparently activates the GATA-2 gene (Brewer et al., 1995) .
Comparing the distribution of HNF4o~ and HNF4/3 in the egg with the fate map defining the prospective tissues (see Fig. 6 ), it is evident that HNF4 is not restricted to the anlagen of the pronephros, liver and stomach that lead to the tissues'-expressing HNFla. Most notably, HNF4 is in the animal region giving rise to the epidermis and neural structures. Although we cannot exclude that in early stages of embryogenesis HNFhx expression is broader than at later stages, a finding that has been documented for MyoD expression (Rupp and Weintraub, 1991) , we also consider the notion that HNF4 needs another signal to be activated. This hypothesis is supported by our finding that in excised animal caps containing endogenous HNF4a and HNF4/3 protein, HNFla transcription is not activated when cultured up to 3 days in the absence of any embryonic inducer (Fig.  7) . However, as illustrated in Fig. 7 these animal caps will produce HNFlc~ if they are treated with the mesoderm inducer activin A, whereas the amount of HNF4ce and/3 does not change significantly. This observation is significant as it links the function of a transcription factor with an embryonic inducer. Activin A is a member of the TGF/3 family and has been shown to act as a morphogen, since it elicits differential responses depending on its concentration (reviewed in Smith, 1993) . Although in the intact embryo the molecular identity of the activin signal is not determined, it is well established that an endogenous activinlike signal is derived from the vegetal region (reviewed in Asashima, 1994; Slack, 1994; Smith, 1995; Harger and Gurdon, 1996) and thus forms an activity gradient that opposes the distribution of the transcription factors HNF4c~ and HNF4/3 (Fig. 6) . We speculate that in the equatorial zone these two gradients generate appropriate conditions to activate HNFlo~ gene transcription. In fact in the central part of this region the pronephros anlage is located and the pronephros is the tissue where HNFlc~ is strongly expressed in the animal caps oo,,o' ¢,
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HNFla Fig. 7 . Activin A treatment of animal caps induces HNFlc~. Animal caps were dissected from blastulae and incubated for 3 days in the absence of any inducers or in the presence of retinoic acid (10 -5 M), activin A (10 ng/ ml) or both (Weber et al., 1996b) . HNF4c~, HNF4/3 and HNFI~ were determined on Western blots using specific antibodies. The lower panel corresponds to the experiment in Fig. 6B of Weber et al. (1996b). developing embryos (Weber et al., 1996b) . From the ventral and dorsal part of the equatorial region the ventral mesoderm (blood) and dorsal mesoderm (muscle and notochord) are derived, tissues that lack HNFI~ expression. Therefore, we believe that in these regions of the embryo the conditions are not favorable for HNFlc¢ gene activation and we propose that some dorsal and ventral signals have an inhibitory effect on HNFlo~ activation. To explore this possibility we are currently investigating whether embryonic inducers known to be derived from the ventral or dorsal side (reviewed in Hogan, 1996) or transcription factors with dorsalizing (e.g. goosecoid; Niehrs et al., 1994) or ventralizing properties (e.g. Xvent-1 and Xvent-2; Onichtchouk et al., 1996) influence HNFI~ gene expression. We thus expect to further define the pattern of embryonic inducers and transcription factors that modulate the restricted expression of HNFlu in the embryo.
Our observation that activin A leads in explanted animal caps to transcriptional activation of the HNFlc¢ gene fits well with the fact that the mesoderm inducer activin A is known to induce pronephric tubules. This differentiation process is especially prominent if retinoic acid is included (Moriya et al., 1993) . Under these induction conditions we could observe pronephric tubules that specifically stain with a pronephros marker and contain HNFlo~ in the nuclei (Weber et al., 1996b) . In addition, these explants also differentiated into cells with endodermal characteristics that also contain nuclear HNFlc¢. Both these cellular differentiation processes occurred in the presence of retinoic acid, but the transcription factor HNFlc¢ is also induced in the absence of retinoids, although to a lower extent, by activin A (see Fig. 7 ). This correlates to the observation that activin A alone induces pronephric differentiation less frequently (Moriya et al., 1993) , but still results in the induction of endodermal cells (Jones et al., 1993) .
The HNF4 binding site is an activin responsive element
The possibility to induce HNFlc~ gene transcription in animal caps by activin A treatment allowed us to define the HNFlot promoter element that receives the morphogen signal. Therefore, we injected HNFlc~ promoter constructs into the fertilized egg and explanted animal caps at the blastula stage. We could show that the injected promoter was activated specifically by activin A treatment. Using various promoter constructs we demonstrated that the HNF4 binding site exclusively receives the activin A signal and thus is an activin response element (Weber et al., 1996b) . Using similar approaches activin response elements have been recently identified in the goosecoid (Watabe et al., 1995) , the Mix.2 (Huang et al., 1995) and the XFD-I' (Kaufmann et al., 1996) promoter. As all these response elements differ in their nucleotide sequence, it seems likely that the activin A signal transduction pathway has a multitude of target sequences. However, in contrast to goosecoid, Mix.2 and XFD-I', which were shown to be direct response genes (reviewed in Dawid, 1994) , the activation of HNFlot gene might be an indirect effect. This is supported by our observation that the induction of HNFlc~ protein is quite slow, requiring at least 6 h (Weber et al., 1996b) , and similar kinetics are obtained if HNFlc¢ transcription is measured by RT-PCR (Nastos et al., in preparation) . In fact, the accumulation of HNFlo~ mRNA is too slow to allow inhibition of protein synthesis by cycloheximide, the standard technique to judge whether the induction process occurs in the absence of protein synthesis, and thus is an immediate transcriptional response. This is in contrast to the activation of the goosecoid, Mix.2 and XFD-I' promoters that are activated even in the presence of the protein synthesis inhibitor and are therefore immediate transcriptional response genes (reviewed in Dawid, 1994) .
Recently, it has been shown that members of the Smad family are intermediates of the activin A response (reviewed in Derynck and Zhang, 1996; Massagur, 1996) . However, these components are already present in the egg and are in fact involved in the direct activation mechanism by activin A (Baker and Harland, 1996 et al., 1992; Krieg et al., 1993) . HNF4c~ and HNF4/3 are denoted for simplicity by a single symbol as we have no evidence of differential function in early development (Holewa et al., 1997) . DCoH is drawn as a homo-tetramer in the absence of HNF1 proteins and as hetero-tetramer in the presence of HNFla or HNF1/3 based on the structural data (Cronk et al., 1996; Suck and Ficner, 1996) . In panel 4 HNFI~ and HNF1/3 are shown within the same tetramer to illustrate this potential combination, although complexes containing either the a or/3 form of HNF1 are likely to exist as well (Tronche and Yaniv, 1992) .
member of the steroid receptor superfamily (Sladek, 1994), we consider the possibility that an as yet unknown ligand may activate the maternal HNF4~ and/3 proteins that are present in the animal caps (see Fig. 7 ). Alternatively, tyrosine phosphorylation (Ktistaki et al., 1995) Demartis et al., 1994. seen in animal caps differs from the events occurring in the entire embryo where HNFI~ transcripts appear very early (see Fig. 1 ). This difference may reflect the fact that normally the region of the animal caps will develop to epidermis and neuroectoderm, but never to pronephros, gut or liver (see fate map in Fig. 6 ). The animal cap region therefore might reflect only a part of the processes leading to the activation of HNFlc~ in the entire embryo. This assumption correlates with our finding that in animal cap explants an injected HNFlc¢ promoter construct requires the HNF4 binding site exclusively, whereas in corresponding experiments in the entire embryo the OZ element and the HNF1 binding site contribute to the activity (see Fig. 3 ). This observation suggests some differential composition of the animal cap compared to the entire embryo and implies that this difference is involved in the early induction process seen in the entire embryo.
Our current concept of the molecular events leading to HNFI~ gene expression
Based on all the data available we propose that embryonic activation of HNFlc~ can be considered as a multistep process that can be divided into at least four different steps (Fig. 8) . Initially, in the fertilized egg the maternal regulatory factors OZ-1, HNF4a, HNF4/3 and DCoH are present. At this stage the a and/3 forms of HNF4 are distributed in a gradient from the animal to the vegetal pole (Holewa et al., 1996; Holewa et al., 1997) , whereas DCoH is uniformly distributed (Pogge v. Strandmann and Ryffel, 1995) . OZ-1 is characterized so far only as a binding activity and its localization has not been investigated (Ovsenek et al., 1992) . We believe that at mid blastula transition when zygotic gene transcription starts, OZ-1 activates the HNFlc¢ promoter. This early action of OZ-1 is consistent with the early function in the activation of the N-CAM and GS 17 promoter (Ovsenek et al., 1992) . It also accounts for our observation that deletion of the OZ element completely abolishes any HNFla promoter activation (Holewa et al., 1996) . We assume that subsequently the maternal HNF4a and HNF4/3 act on the HNFlot promoter. Both factors may have similar function, although transfection experiments suggest that the ot protein is a stronger transactivator compared to the/3 protein (Holewa et al., 1997) .
After mid blastula transition zygotic HNF1/3 protein accumulates prior to HNFla (Fig. 2) , and we therefore assume that the /3 form of HNF1 acts initially on the HNF1 binding site of the HNFlc~ promoter. At this stage DCoH, present as a maternal component but also as a zygotically activated gene product, may support the action of HNF1/3. As soon as substantial HNFla protein has accumulated we expect an autoregulation of the HNFlc¢ promoter by its own gene product. At this late stage we assume that OZ-1 action ceases as the OZ-1 binding activity disappears (Ovsenek et al., 1992) . The regulation of HNFtot will be maintained by HNFlc¢ itself, HNF1/3, the cofactor DCoH as well as HNF4c~ and HNF4/3. As shown in Fig. 9 , these factors show a distinct expression pattern in the adult tissues and therefore each cell type has a unique set of activators of the HNFlc~ promoter. Clearly, the stomach and intestine lack significant levels of the cofactor DCoH and of the transcription factor HNF4/3 and therefore in these tissues HNFlot is under a distinct regulatory control compared to the liver and kidney. Based on the data available in mammals (Tian and Schibler, 1991; Kuo et al., 1992) , we assume that this picture is far more complex, because other transcription factors are expected to regulate the HNFlc~ promoter as well. But this model illustrates that distinct factors regulate the HNFlc~ promoter in a tissue-specific way. Clearly, this pattern is laid down during the various stages of development and we are just beginning to understand the various parameters that shape these events.
Future prospects
Our approach to analyzing the embryonic activation of the gene encoding the tissue-specific transcription factor HNFlot has provided a significant insight into the molecular events. Most notably, we have identified maternal components mediating HNFla activation in the embryos and thus have identified a transcriptional cascade in vertebrates. The available data suggest that our model also closely reflects the events occurring in mammalian development. With the potential to generate stable transgenic Xenopus (reviewed in Slack, 1996) with the pioneering method described by Kroll and Amaya (1996) , we now expect to solve the important question whether the same regulatory elements are needed to get HNFla promoter activation in liver, kidney, gut and pancreas.
